Compare IOL CHEMICALS & PHARM. with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IOL CHEMICALS & PHARM. vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IOL CHEMICALS & PHARM. GLAND PHARMA IOL CHEMICALS & PHARM./
GLAND PHARMA
 
P/E (TTM) x 9.3 - - View Chart
P/BV x 2.8 10.5 26.8% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 IOL CHEMICALS & PHARM.   GLAND PHARMA
EQUITY SHARE DATA
    IOL CHEMICALS & PHARM.
Mar-21
GLAND PHARMA
Mar-21
IOL CHEMICALS & PHARM./
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs8982,784 32.3%   
Low Rs1751,701 10.3%   
Sales per share (Unadj.) Rs335.0211.7 158.3%  
Earnings per share (Unadj.) Rs75.760.9 124.2%  
Cash flow per share (Unadj.) Rs82.467.0 122.9%  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs214.7359.3 59.8%  
Shares outstanding (eoy) m58.71163.59 35.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.610.6 15.1%   
Avg P/E ratio x7.136.8 19.2%  
P/CF ratio (eoy) x6.533.5 19.5%  
Price / Book Value ratio x2.56.2 40.0%  
Dividend payout %7.90-   
Avg Mkt Cap Rs m31,493366,894 8.6%   
No. of employees `000NANA-   
Total wages/salary Rs m1,1563,114 37.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m19,67034,629 56.8%  
Other income Rs m2431,348 18.0%   
Total revenues Rs m19,91335,977 55.3%   
Gross profit Rs m5,91813,022 45.4%  
Depreciation Rs m389988 39.4%   
Interest Rs m5834 170.9%   
Profit before tax Rs m5,71413,348 42.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2683,378 37.5%   
Profit after tax Rs m4,4469,970 44.6%  
Gross profit margin %30.137.6 80.0%  
Effective tax rate %22.225.3 87.7%   
Net profit margin %22.628.8 78.5%  
BALANCE SHEET DATA
Current assets Rs m11,64551,236 22.7%   
Current liabilities Rs m4,3285,125 84.4%   
Net working cap to sales %37.2133.2 27.9%  
Current ratio x2.710.0 26.9%  
Inventory Days Days58 62.2%  
Debtors Days Days671 7.9%  
Net fixed assets Rs m5,87813,724 42.8%   
Share capital Rs m587164 358.9%   
"Free" reserves Rs m12,01758,615 20.5%   
Net worth Rs m12,60458,778 21.4%   
Long term debt Rs m039 0.0%   
Total assets Rs m17,52364,961 27.0%  
Interest coverage x99.0392.3 25.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.5 210.6%   
Return on assets %25.715.4 166.9%  
Return on equity %35.317.0 207.9%  
Return on capital %45.822.8 201.3%  
Exports to sales %26.883.8 32.0%   
Imports to sales %00-   
Exports (fob) Rs m5,27229,021 18.2%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,27229,021 18.2%   
Fx outflow Rs m5,00416,878 29.6%   
Net fx Rs m26812,142 2.2%   
CASH FLOW
From Operations Rs m3,7986,049 62.8%  
From Investments Rs m-3,173-15,240 20.8%  
From Financial Activity Rs m-58312,385 -4.7%  
Net Cashflow Rs m433,230 1.3%  

Share Holding

Indian Promoters % 39.9 0.0 -  
Foreign collaborators % 0.0 58.1 -  
Indian inst/Mut Fund % 0.2 22.5 0.7%  
FIIs % 0.0 10.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 60.1 41.9 143.5%  
Shareholders   10,561 98,203 10.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IOL CHEMICALS & PHARM. With:   MERCURY LAB.  ABBOTT INDIA  DIVIS LABORATORIES  PARMAX PHARMA  KILITCH DRUGS  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

IOL CHEMICALS & PHARM. 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IOL CHEMICALS & PHARM. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IOL CHEMICALS & PHARM.. Also includes updates on the valuation of IOL CHEMICALS & PHARM..

IOL CHEMICALS & PHARM. Announces Quarterly Results (1QFY22); Net Profit Down 47.5% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, IOL CHEMICALS & PHARM. has posted a net profit of Rs 670 m (down 47.5% YoY). Sales on the other hand came in at Rs 5 bn (up 12.7% YoY). Read on for a complete analysis of IOL CHEMICALS & PHARM.'s quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IOL CHEMICALS & PHARM. SHARE PRICE


Oct 14, 2021 (Close)

TRACK IOL CHEMICALS & PHARM.

  • Track your investment in IOL CHEMICALS & PHARM. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IOL CHEMICALS & PHARM.

IOL CHEMICALS & PHARM. 8-QTR ANALYSIS

COMPARE IOL CHEMICALS & PHARM. WITH

MARKET STATS